Discover how vitronectin, identified through LC-MS/MS technology, could revolutionize early detection of metastatic breast cancer through a simple blood test.
Discover how the Lactate/NAA ratio measured by Proton MRS can predict brain cell death in newborns with hypoxia-ischemia, revolutionizing neonatal care.
Discover how Activin A, a common protein, is revolutionizing prostate cancer detection and prognosis by revealing hidden messages in our bloodstream.
Discover how circulating cell-free DNA (cfDNA) in blood may predict cognitive decline years before symptoms appear. Learn about the breakthrough research linking cfDNA to dementia risk.
Discover how miR-9 is revolutionizing meningioma prognosis as a novel biomarker for predicting malignant transformation in brain tumors.
Discover how MRP-1 protein serves as a predictive biomarker for chemotherapy response in soft tissue sarcomas, revolutionizing personalized cancer treatment.
Exploring the role of survivin expression in CML progression, treatment resistance, and its potential as a prognostic biomarker.
Discover how the M30 antigen, a fragment from dying liver cells, serves as an early warning signal for pre-diabetes and impaired glucose tolerance.
Discover how PITX2 serves as a predictive biomarker for esophageal squamous cell carcinoma, revolutionizing personalized cancer treatment and prognosis.